The human endothelin-1 (ET-1) gene under the control of its natural promoter was transferred into the germline of mice. The transgene was expressed predominantly in the brain, lung, and kidney. Transgene expression was associated with a pathological phenotype manifested by signs such as age-dependent development of renal cysts, interstitial fibrosis of the kidneys, and glomerulosclerosis leading to a progressive decrease in glomerular filtration rate. This pathology developed in spite of only slightly elevated plasma and tissue ET-1 concentrations. Blood pressure was not affected even after the development of an impaired glomerular filtration rate. Therefore, these transgenic lines provide a new blood pressure-independent animal model of ET-1-induced renal pathology leading to renal fibrosis and fatal kidney disease.
B Hocher, C Thöne-Reineke, P Rohmeiss, F Schmager, T Slowinski, V Burst, F Siegmund, T Quertermous, C Bauer, H H Neumayer, W D Schleuning, F Theuring
Title and authors | Publication | Year |
---|---|---|
Endothelin
AP Davenport, KA Hyndman, N Dhaun, C Southan, DE Kohan, JS Pollock, DM Pollock, DJ Webb, JJ Maguire |
Pharmacological reviews | 2016 |
Endothelial dysfunction and vascular disease - a 30th anniversary update
PM Vanhoutte, H Shimokawa, M Feletou, EH Tang |
Acta physiologica (Oxford, England) | 2016 |
Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease
R Komers, H Plotkin |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2016 |
Endothelin‐1 Drives Epithelial‐Mesenchymal Transition in Hypertensive Nephroangiosclerosis
TM Seccia, B Caroccia, F Gioco, M Piazza, V Buccella, D Guidolin, E Guerzoni, B Montini, L Petrelli, E Pagnin, V Ravarotto, AS Belloni, LA Calò, GP Rossi |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2016 |
Advances in Pharmacology
O Baretella, PM Vanhoutte |
Advances in Pharmacology | 2016 |
Heterotrimeric G protein signaling in polycystic kidney disease
T Hama, F Park |
Physiological genomics | 2016 |
Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
AS AL-Onazi, NM AL-Rasheed, HA Attia, NM AL-Rasheed, RM Ahmed, MA AL-Amin, C Poizat |
Journal of Pharmacy and Pharmacology | 2016 |
Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
MG Boels, MC Avramut, A Koudijs, MJ Dane, DH Lee, J der Vlag, AJ Koster, AJ van Zonneveld, E Faassen, HJ Gröne, BM van Berg, TJ Rabelink |
Diabetes | 2016 |
Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF- β 1/Smad3 signaling pathway
NM Al-Rasheed, NM Al-Rasheed, MA Al-Amin, IH Hasan, HN Al-Ajmi, RA Mohammad, HA Attia |
Archives Of Physiology And Biochemistry | 2016 |
Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis
R Raina, L Lou, B Berger, B Vogt, AS Do, R Cunningham, P Vasavada, K Herrmann, K Dell, M Simonson |
BMC Nephrology | 2016 |
Lack of an apparent role for endothelin‐1 in the prolonged reduction in renal perfusion following severe unilateral ischemia‐reperfusion injury in the mouse
EI Boesen |
Physiological Reports | 2016 |
Therapeutic potential of endothelin receptor antagonism in kidney disease
A Czopek, R Moorhouse, DJ Webb, N Dhaun |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2016 |
Association of Endothelin-1 rs5370 G>T gene polymorphism with the risk of nephrotic syndrome in children
M Hashemi, S Sadeghi-Bojd, S Aryanezhad, M Rezaei |
Journal of Nephropathology | 2016 |